Top-News

Alaunos Therapeutics Inc. Aktie

Aktie
WKN:  ISIN:  US98973P3091 US-Symbol:  TCRT
2,0161 €
+0,0382 €
+1,92%
2,12 $ 12.12.24
Handeln Depot/Watchlist
Aktienanzahl *
24,06 Mio.
Marktkapitalisierung *
55,41 Mio. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 18.07.2024

Alaunos Therapeutics Inc. News

28.09.22 - PR Newswire
Thinking about buying stock in Frontier Communications, Edgio, Alaunos Therapeutics, Heartbeam, or Blue Apron?
Thinking about buying stock in Frontier Communications, Edgio, Alaunos Therapeutics, Heartbeam, or Blue Apron? PR Newswire
27.09.22 - PR Newswire
Thinking about buying stock in Kiora Pharmaceuticals, X4 Pharmaceuticals, Ayala Pharmaceuticals, Aquestive Therapeutics, or Alaunos Therapeutics?
Thinking about buying stock in Kiora Pharmaceuticals, X4 Pharmaceuticals, Ayala Pharmaceuticals, Aquestive Therapeutics, or Alaunos Therapeutics? PR Newswire
23.09.22 - PR Newswire
Thinking about buying stock in Rubius Therapeutics, NextPlat, Seres Therapeutics, Cassava Sciences, or Alaunos Therapeutics?
Thinking about buying stock in Rubius Therapeutics, NextPlat, Seres Therapeutics, Cassava Sciences, or Alaunos Therapeutics? PR Newswire
22.09.22 - PR Newswire
Thinking about buying stock in FREYR Battery, Palantir Technologies, Carnival Corp, Novavax, or Alaunos Therapeutics?
Thinking about buying stock in FREYR Battery, Palantir Technologies, Carnival Corp, Novavax, or Alaunos Therapeutics? PR Newswire
14.09.22 - PR Newswire
Thinking about buying stock in Caladrius Biosciences, Timber Pharmaceuticals, 89Bio, Alaunos Therapeutics, or SoFi Technologies?
Thinking about buying stock in Caladrius Biosciences, Timber Pharmaceuticals, 89Bio, Alaunos Therapeutics, or SoFi Technologies? PR Newswire
07.09.22 - PR Newswire
Thinking about buying stock in Aquestive Therapeutics, Alaunos Therapeutics, Ardelyx, IVERIC Bio, or Nio?
Thinking about buying stock in Aquestive Therapeutics, Alaunos Therapeutics, Ardelyx, IVERIC Bio, or Nio? PR Newswire
25.08.22 - PR Newswire
Thinking about buying stock in Alaunos Therapeutics, BioSig Technologies, Futu Holdings, Hall of Fame Resort & Entertainment, or Verve Therapeutics?
Thinking about buying stock in Alaunos Therapeutics, BioSig Technologies, Futu Holdings, Hall of Fame Resort & Entertainment, or Verve Therapeutics? PR Newswire
10.06.22 - PR Newswire
Thinking about buying stock in Alaunos Therapeutics, Youdao, New Oriental Education, Paltalk, or Bilibili?
Thinking about buying stock in Alaunos Therapeutics, Youdao, New Oriental Education, Paltalk, or Bilibili? PR Newswire
06.10.21 - PR Newswire
Thinking about buying stock in Acer Therapeutics, Ziopharm Oncology, Nutriband, Ocugen, or Flux Power?
Thinking about buying stock in Acer Therapeutics, Ziopharm Oncology, Nutriband, Ocugen, or Flux Power? PR Newswire
05.10.21 - PR Newswire
Thinking about buying stock in Agrify, Rush Street Interactive, Ocugen, Nine Energy Service, or Ziopharm Oncology?
Thinking about buying stock in Agrify, Rush Street Interactive, Ocugen, Nine Energy Service, or Ziopharm Oncology? PR Newswire
07.09.21 - PR Newswire
Thinking about buying stock in Adaptimmune Therapeutics, Ziopharm Oncology, Uniqure NV, GlycoMimetics, or AbCellera Biologics?
Thinking about buying stock in Adaptimmune Therapeutics, Ziopharm Oncology, Uniqure NV, GlycoMimetics, or AbCellera Biologics? PR Newswire
14.08.18 - PR Newswire
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Ziopharm Oncology, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Ziopharm Oncology, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire
24.05.18 - The Motley Fool
Wie wir Krebs besiegen: Hier die Argumente und der Hot Stock Ziopharm Oncology
Es gibt sensationelle Erfolge bei der Krebsimmuntherapie mit Checkpoint-​Inhibitoren und insbesondere mit T-​Zell-Therapien, die erstaunlich wirksam und zielgerichtet sind. Daher ...
01.09.17 - The Motley Fool
Gilead hat noch nicht genug
Die Investoren bekamen am Montagmorgen eine angenehme Überraschung von Gilead Sciences (WKN:885823). Das große Biotech kündigte Pläne zur Übernahme von Kite ...
10.01.17 - PR Newswire
ZIOPHARM and Intrexon Announce Cooperative Research and Development Agreement with the National Cancer Institute Utilizing Sleeping Beauty System to Generate T cells Targeting Neoantigens
ZIOPHARM and Intrexon Announce Cooperative Research and Development Agreement with the National Cancer Institute Utilizing Sleeping Beauty System to Generate T cells ...
05.08.16 - PR Newswire
Lifshitz & Miller Law Firm Announces Investigation of American Renal Associates Holdings, Inc., CytRx Corporation, El Pollo Loco Holdings, Inc., EndoChoice Holdings, Inc., Full Circle Capital Corp
Lifshitz & Miller Law Firm Announces Investigation of American Renal Associates Holdings, Inc., CytRx Corporation, El Pollo Loco Holdings, Inc., EndoChoice Holdings, Inc., Full ...
15.07.16 - PR Newswire
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of ZIOPHARM Oncology, Inc. (ZIOP)
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of ZIOPHARM Oncology, Inc. (ZIOP) PR Newswire
15.07.16 - PR Newswire
Shareholder Alert: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ZIOPHARM Oncology, Inc. - ZIOP
Shareholder Alert: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ZIOPHARM Oncology, Inc. - ZIOP PR Newswire
22.12.15 - The Motley Fool
3 Biotech-Aktien, von denen ich die Finger lasse
Aktien von Biotech-​Unternehmen sind für ihre rasanten Achterbahnfahrten bekannt; und dies aus gutem Grund: 90% aller Medikamente scheitern bei klinischen Studien am ...
10.08.15 - PR Newswire
Intrexon Announces Second Quarter and First Half 2015 Financial Results
Intrexon Announces Second Quarter and First Half 2015 Financial Results - Record quarterly revenues of $44.9 million and Adjusted EBITDA of $54.4 million - - GAAP net loss of ...

Newssuche

Videos

newspaper
13:40 Uhr
TRADING Insights Webinar vom 12.12.24
Themen: Aktienmarkt-​Entwicklung, Soft-​Commodities, wie Baumwolle, Kakao, Orangensaft, aber auch die ... Mehr »